IT1206822B - Derivati di glicina in qualita' di agenti preventivi e terapeutici del le complicanze diabetiche - Google Patents

Derivati di glicina in qualita' di agenti preventivi e terapeutici del le complicanze diabetiche

Info

Publication number
IT1206822B
IT1206822B IT8748116A IT4811687A IT1206822B IT 1206822 B IT1206822 B IT 1206822B IT 8748116 A IT8748116 A IT 8748116A IT 4811687 A IT4811687 A IT 4811687A IT 1206822 B IT1206822 B IT 1206822B
Authority
IT
Italy
Prior art keywords
preventive
therapeutic agents
diabetic complications
glycine derivatives
glycine
Prior art date
Application number
IT8748116A
Other languages
English (en)
Other versions
IT8748116A0 (it
Inventor
Murase Masao
Maruo Shigeaki
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of IT8748116A0 publication Critical patent/IT8748116A0/it
Application granted granted Critical
Publication of IT1206822B publication Critical patent/IT1206822B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT8748116A 1986-06-27 1987-06-26 Derivati di glicina in qualita' di agenti preventivi e terapeutici del le complicanze diabetiche IT1206822B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15214986 1986-06-27

Publications (2)

Publication Number Publication Date
IT8748116A0 IT8748116A0 (it) 1987-06-26
IT1206822B true IT1206822B (it) 1989-05-03

Family

ID=15534103

Family Applications (2)

Application Number Title Priority Date Filing Date
IT8748116A IT1206822B (it) 1986-06-27 1987-06-26 Derivati di glicina in qualita' di agenti preventivi e terapeutici del le complicanze diabetiche
IT8748117A IT1206823B (it) 1986-06-27 1987-06-26 Derivati di glicina quali agenti preventivi e terapeutici per le complicanze diabetiche

Family Applications After (1)

Application Number Title Priority Date Filing Date
IT8748117A IT1206823B (it) 1986-06-27 1987-06-26 Derivati di glicina quali agenti preventivi e terapeutici per le complicanze diabetiche

Country Status (6)

Country Link
US (2) US4785018A (it)
JP (2) JPS6399057A (it)
DE (2) DE3721222A1 (it)
FR (2) FR2600647B1 (it)
GB (2) GB2193210B (it)
IT (2) IT1206822B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196849B (it) * 1986-12-16 1988-11-25 Rotta Research Lab Nuovi derivati degli acidi 5 pentilammino 5 oxo pentaoico e 4 pentilammino 4 oxo butanoico ad attivita antagonista della colecistochinina e procedimento per la loro preparazione
CA1307537C (en) * 1987-12-23 1992-09-15 Jay E. Wrobel N-naphthoylglycines as aldose reductase inhibitors
US4962224A (en) * 1987-12-23 1990-10-09 American Home Products Corporation N-naphthoylglycines as aldose reductase inhibitors
US5627193A (en) * 1995-02-09 1997-05-06 Mitsui Toatsu Chemicals, Inc. Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds
CA2238298A1 (en) * 1995-11-24 1997-06-19 Luca Francesco Raveglia Quinoline derivatives
WO1998041506A1 (en) * 1997-03-14 1998-09-24 Smithkline Beecham Corporation Novel quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain
WO2002098421A1 (en) * 2001-06-05 2002-12-12 University Of Maryland, Baltimore Novel treatment for neurological and psychiatric disorders
WO2006034491A2 (en) * 2004-09-23 2006-03-30 Bayer Pharmaceuticals Corporation Phenyl-substituted quinoline and quinazoline compounds for the treatment of diabetes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928610A (en) * 1970-06-06 1975-12-23 Hoechst Ag Benzene sulfonyl-urea preparation for treatment of diabetes mellitus and a method for treatment
US3939269A (en) * 1971-04-26 1976-02-17 Hoechst Aktiengesellschaft Benzenesulfon YL-semicarbazides for lowering blood sugar levels
JPS5216367A (en) * 1975-07-21 1977-02-07 Rikagaku Kenkyusho Plant growth control agent
US4195984A (en) * 1979-03-12 1980-04-01 Abbott Laboratories Herbicides derived from dihalo isonicotinoyl derivatives of amino acids
AU544067B2 (en) * 1981-03-02 1985-05-16 Wyeth-Ayerst Canada Inc. Thioamides and amides. treatment of diabetes
CA1176269A (en) * 1981-03-02 1984-10-16 Kazimir Sestanj N-naphthoylglycine derivatives
CA1182472A (en) * 1981-03-02 1985-02-12 Kazimir Sestanj N-[(2-naphthalenyl)thioxomethyl]glycine derivatives
US4337265A (en) * 1981-08-21 1982-06-29 Ayerst, Mckenna & Harrison Inc. Cyclohepta[b]pyrrole derivatives
US4604406A (en) * 1984-11-16 1986-08-05 Ayerst, Mckenna & Harrison, Inc. N-[6-methoxy-5-(perfluoroalkyl)-1-naphtholyl]-N-methylglycines and their thionaphthoyl analogs

Also Published As

Publication number Publication date
FR2600646A1 (fr) 1987-12-31
FR2600647A1 (fr) 1987-12-31
FR2600647B1 (fr) 1991-10-18
DE3721223A1 (de) 1988-01-14
DE3721223C2 (it) 1991-11-14
GB2193210B (en) 1990-03-28
US4785018A (en) 1988-11-15
IT8748116A0 (it) 1987-06-26
IT1206823B (it) 1989-05-03
GB8715055D0 (en) 1987-08-05
DE3721222A1 (de) 1988-01-14
GB2192002A (en) 1987-12-31
GB2192002B (en) 1990-04-11
GB2193210A (en) 1988-02-03
US4970214A (en) 1990-11-13
GB8715056D0 (en) 1987-08-05
IT8748117A0 (it) 1987-06-26
FR2600646B1 (fr) 1990-01-26
JPS6399057A (ja) 1988-04-30
JPS63119455A (ja) 1988-05-24

Similar Documents

Publication Publication Date Title
DE3781263T2 (de) Peptid-derivate und deren verwendung in der therapie.
IT1236831B (it) Apparecchio per il trattamento dell'intestino in particolare per enteroclisma
EP0441119A3 (en) The use of l-arginine in the treatment of hypertension and other vascular disorders
DK90089D0 (da) Hudbehandlingspraeparat
IT8768027A0 (it) Derivati di 1 piperazinil pirimidina loro preparazione e impiego in terapia e cosmesi
DK295190A (da) Kosmetik- og hudbehandlingssammensaetninger
IT8868118A0 (it) Composizione e procedimento per il trattamento e la cura dei capelli
PT87554A (pt) Didinfecting and sterilizing composition
IT9067434A0 (it) Procedimento per migliorare l'efficacia terapeutica di corticosteroidi liposolubili e composizione per l'attuazione di tale procedimento
IT1206822B (it) Derivati di glicina in qualita' di agenti preventivi e terapeutici del le complicanze diabetiche
MC1337A1 (fr) Interferon de fibroblastes humains sous la forme d'une proteine homogene et sa preparation
EP0510063A4 (en) Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues
EP0437026A3 (en) Use of tandospirone in the treatment of depression
IL91451A0 (en) Pharmaceutical compositions comprising azapiron compounds and their use in the treatment of addiction
GB2201171B (en) Compositions for use in the treatment of cellulosic materials and their preparation
DE3863200D1 (de) In der krebstherapie verwendbare zusammensetzung auf der basis von aminosaeure und vitaminen.
ATE142503T1 (de) Arzneimittelzubereitung bei der behandlung von tonsillitis
AU3752189A (en) Pharmaceutical compositions and use thereof in treating inflammation
EP0354776A3 (en) Improvements in and relating to semiconductor lasers
EP0267684A3 (en) Human leukocyte interferon composition and skin treatment
IL76758A0 (en) Improvements in or relating to the treatment of trees and bushes
DE3777411D1 (de) Mittel zur verbesserung der perkutanen verabreichung von arzneimitteln.
BR8902395A (pt) Composicao curavel e artigo
RO105585B1 (ro) Compozitie medicamentoasa folosita in tratamentul ulcerului de gamba
LV5819A4 (lv) (-)-benzhidrilsulfinilacetamids ta iegusanas panemiens un ta izmantosana terapija

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19930419